Skip to main content

Search Results - infectious+disease

21 Results Sort By:
Exhaled Breath Condensate Collection Device for Respiratory Pathogen Testing
NU 2020-112 INVENTORS Christina Zelano* Gregory Lane SHORT DESCRIPTION A portable, self-administered exhaled breath condensate (EBC) collection device that enables patients to collect breath samples at home for SARS-CoV-2 or other respiratory pathogen detection, supporting direct, quantitative assessment of a person's infectiousness. BACKGROUND Determining...
Published: 6/17/2026   |   Updated: 6/17/2026   |   Inventor(s):  
Keywords(s): Biomarker, COVID-19, Diagnostics, Infectious disease
Category(s): Life Sciences > Biomarkers & Biomedical Research Tools
Peptide Linkers for Modulating Antigen Immune Response in Cancer Vaccines
SHORT DESCRIPTION A novel non-biologically derived peptide linker technology enabling precise intracellular release of vaccine antigens to enhance immune activation. NU TECH ID NU 2024-124 INVENTORS Chad Mirkin* Weinberg College of Arts and Sciences, Department of Chemistry Tanner Fink *...
Published: 6/16/2026   |   Updated: 6/16/2026   |   Inventor(s):  
Keywords(s): BIO2026, Cancer/Oncology, Immunology, Immunotherapy, Infectious disease, Therapeutics, Vaccine
Category(s): Life Sciences > Therapeutics
Assembly of Vaccines Using Cell-Free Integration of Viral Membrane Proteins into Liposomes
SHORT DESCRIPTION A cell-free method that assembles vaccines by integrating viral membrane proteins into liposomes, enabling rapid prototype production without cold chain requirements. INVENTORS Neha Kamat* McCormick School of Engineering, Department of Biomedical Engineering Hector Aguilar-Carreno Susan...
Published: 6/16/2026   |   Updated: 6/10/2026   |   Inventor(s):  
Keywords(s): BIO2026, Immunology, Infectious disease, Nanomaterials, Nanoparticle, Nanotechnology, Synthetic biology, Vaccine
Category(s): Life Sciences > Biomarkers & Biomedical Research Tools
Piperacillin for Targeted Lyme Disease Treatment
SHORT DESCRIPTION For infectious disease clinicians, this piperacillin-based therapeutic approach targets Lyme disease by inhibiting bacterial cell wall synthesis to reduce disease progression. INVENTORS INVENTORS Brandon Jutras* Northwestern University Feinberg School of Medicine, Department of Microbiology-Immunology ...
Published: 6/3/2026   |   Updated: 5/18/2026   |   Inventor(s):  
Keywords(s): Infectious disease, Targeted therapy, Therapeutics
Category(s): Life Sciences > Therapeutics
Drug Repurposing for Age-Impaired Vascular Repair in COVID-19, Sepsis, and ARDS
SHORT DESCRIPTION Methods and compositions for treating COVID-19, sepsis, acute respiratory distress syndrome (ARDS), and cardiovascular diseases in elderly patients by either inhibiting vascular endothelial injury/inflammation or promoting FOXM1-dependent endothelial regeneration and vascular repair. INVENTORS Youyang Zhao Northwestern...
Published: 6/16/2026   |   Updated: 4/22/2026   |   Inventor(s):  
Keywords(s): ARDS - Acute Respiratory Distress Syndrome, BIO2026, COVID-19, Immunology, Infectious disease, Inflammation, Pulmonary disease, Therapeutics, Vascular disease, Vascular repair
Category(s): Life Sciences > Therapeutics
Antibodies for treatment of coronavirus disease
NU 2023-247 INVENTORS Huiping Liu* Deyu Fang* Hannah Mubarak Andrew Hoffmann Nurmaa Dashzeveg Lamiaa El-Shennawy Juncheng Wei Wuwei Tan Yang Shen SHORT DESCRIPTION Computationally redesigned antibodies targeting SARS-CoV-2 for treating COVID-19. BACKGROUND The continuous evolution of SARS-CoV-2 has allowed the virus to escape most therapeutic...
Published: 2/26/2026   |   Updated: 2/26/2026   |   Inventor(s):  
Keywords(s): Antibody, Artificial Intelligence & Machine Learning, Biologic, Infectious disease, Research tool, Targeted therapy, Therapeutics
Category(s): Life Sciences > Therapeutics
The use of complex or fusion protein of soluble MIC (sMIC) and antibody to treat MIC-negative cancer
NU 2019-146 INVENTORS Jennifer Wu* SHORT DESCRIPTION A fusion protein complex comprising soluble MIC and a non-blocking sMIC-neutralizing antibody that effectively activates CD8 T cells for the treatment of MIC-negative cancer. BACKGROUND Effective T cell co-stimulation is critical for durable tumor control, yet many current immunotherapies...
Published: 6/16/2026   |   Updated: 12/3/2025   |   Inventor(s):  
Keywords(s): Antibody, BIO2026, Biologic, Cancer/Oncology, Immunotherapy, Infectious disease, Research tool, Targeted therapy, Therapeutics
Category(s): Life Sciences > Therapeutics
ACE2+ Exosomes for COVID-19 Decoy Therapy
PROPOSED TITLE: ACE2+ Exosomes for COVID-19 Decoy Therapy NU NUMBER NU 2020-145 INVENTORS Deyu Fang* Huiping Liu* Andrew Hoffmann Emma June Schuster Lamiaa El-Shennawy Nurmaa Dashzeveg SHORT DESCRIPTION This invention provides exosomes loaded with ACE2 protein or viral antigen-specific IgGs for treatment of COVID-19. BACKGROUND The COVID-19...
Published: 4/13/2026   |   Updated: 11/17/2025   |   Inventor(s):  
Keywords(s): COVID-19, Drug delivery, Infectious disease, Targeted therapy, Therapeutics
Category(s): Life Sciences > Therapeutics
Methods for assembling peptides into peptide amphiphile nanofibers
TITLE: Peptide Nanofiber Assembly for Enhanced Therapeutic Delivery NU 2020-081 SHORT DESCRIPTION This technology uses self-assembling peptide amphiphile nanofibers to protect and deliver therapeutic peptides. It reduces degradation and improves delivery efficiency for advanced treatment applications. BACKGROUND Peptide therapeutics offer promise...
Published: 6/16/2026   |   Updated: 10/21/2025   |   Inventor(s):  
Keywords(s): BIO2026, Drug delivery, Infectious disease, Nanomaterials, Neurodegenerative disease, Neurologic disease, Neurology, Neurovascular, TBI - Traumatic brain injury, Therapeutics
Category(s): Life Sciences > Therapeutics
Self-powered, bioresorbable drug release systems
NU 2023-045 INVENTORS John Rogers* Colin Franz* Yamin Zhang SHORT DESCRIPTION Northwestern and Shirley Ryan AbilityLab researchers have developed a novel, self-powered, bioresorbable drug delivery system that enables light-controlled, targeted drug release without the need for surgical removal post-treatment. BACKGROUND Current drug delivery systems...
Published: 11/6/2025   |   Updated: 5/8/2025   |   Inventor(s):  
Keywords(s): Biomaterials, Cancer/Oncology, Drug delivery, Infectious disease, Medical device, Therapeutics
Category(s): Life Sciences > Healthcare Devices, Tools & IT
1 2 3